Literature DB >> 6353235

The pharmacology and clinical use of methotrexate.

J Jolivet, K H Cowan, G A Curt, N J Clendeninn, B A Chabner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6353235     DOI： 10.1056/NEJM198311033091805

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  148 in total

Review 1.  Management of graft-versus-host disease in paediatric bone marrow transplant recipients.

Authors:  M Zecca; F Locatelli
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

Review 2.  Drug-induced acute kidney injury in children.

Authors:  Lauren N Faught; Michael J E Greff; Michael J Rieder; Gideon Koren
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

3.  Dosing algorithm to target a predefined AUC in patients with primary central nervous system lymphoma receiving high dose methotrexate.

Authors:  Markus Joerger; Andrés J M Ferreri; Stephan Krähenbühl; Jan H M Schellens; Thomas Cerny; Emanuele Zucca; Alwin D R Huitema
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

4.  Methotrexate-mediated inhibition of RAD51 expression and homologous recombination in cancer cells.

Authors:  Li-Qing Du; Xiao-Qing Du; Jian-Qiang Bai; Yan Wang; Qing-Shan Yang; Xiao-Chun Wang; Peng Zhao; Hong Wang; Qiang Liu; Fei-Yue Fan
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-25       Impact factor: 4.553

5.  The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number.

Authors:  Jannie Gregers; Ib Jarle Christensen; Kim Dalhoff; Birgitte Lausen; Henrik Schroeder; Steen Rosthoej; Niels Carlsen; Kjeld Schmiegelow; Curt Peterson
Journal:  Blood       Date:  2010-03-24       Impact factor: 22.113

6.  Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy.

Authors:  Kunihiro Suzuki; Kosuke Doki; Masato Homma; Hirofumi Tamaki; Satoko Hori; Hisakazu Ohtani; Yasufumi Sawada; Yukinao Kohda
Journal:  Br J Clin Pharmacol       Date:  2008-11-17       Impact factor: 4.335

7.  Identification and characterization of a 66-68-kDa protein as a methotrexate-binding protein in murine leukemia L1210 cells.

Authors:  Tuoen Liu; Allison Dean; Saint Ashwini; Peter P Sheridan; Alok Bhushan; James C K Lai; Shousong Cao; Christopher K Daniels
Journal:  Cell Stress Chaperones       Date:  2012-10-23       Impact factor: 3.667

8.  Evaluation of methotrexate tissue exposure by in situ microdialysis in a rat model.

Authors:  O Ekstrøm; A Andersen; D J Warren; K E Giercksky; L Slørdal
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  Pharmacokinetic application of a bio-analytical LC-MS method developed for 5-fluorouracil and methotrexate in mouse plasma, brain and urine.

Authors:  Vaishnavi Ganti; Ellen A Walker; Swati Nagar
Journal:  Biomed Chromatogr       Date:  2013-03-12       Impact factor: 1.902

10.  Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.

Authors:  Lisa R Treviño; Noriko Shimasaki; Wenjian Yang; John C Panetta; Cheng Cheng; Deqing Pei; Diana Chan; Alex Sparreboom; Kathleen M Giacomini; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.